Third-quarter flash report came in
Analyst consensus available
Gynaecological product gets green light, milestone payment coming
Capacities have been expanded
Vrylar, jointly developed with US partner AbbVie, is the subject of the positive news
The pharmaceutical manufacturer did not disappoint
Analysts surveyed
Higher TP with 'Overweight' recommendation
Richter will become 100% owner of the two companies for €112 million
Erik Bogsch replaced by E. Szilveszter Vizi
From Erste
Just to be clear about the impacts
Signs Head of Terms contract with Mithra
Management addresses Q3 earnings and more
Results largely exceed analyst expectations, though
Battle against endometriosis continues
Share purchase programme is far from over, though
Particularly in relation to Vraylar
10% growth forecast raised
Q2 report due on Friday